Pages that link to "Q88126656"
Jump to navigation
Jump to search
The following pages link to β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers (Q88126656):
Displaying 10 items.
- Identifying aggressive forms of endometrioid-type endometrial cancer: new insights into molecular subtyping (Q36263947) (← links)
- Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study (Q37429034) (← links)
- CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence. (Q40986278) (← links)
- Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials (Q45848384) (← links)
- Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes (Q57022602) (← links)
- Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association. (Q64905628) (← links)
- Proteogenomic Characterization of Endometrial Carcinoma (Q89720874) (← links)
- Impact of TP53 immunohistochemistry on the histological grading system for endometrial endometrioid carcinoma (Q91450856) (← links)
- Clinical actionability of molecular targets in endometrial cancer (Q92461143) (← links)
- Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers (Q92609660) (← links)